| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 28, 2023 |
| Accession Number: | 0001213900-23-013709 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 28, 2023 |
| Accession Number: | 0001213900-23-013709 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/2/2022 | $6.50 → $5.50 | Equal-Weight | Morgan Stanley |
| 3/2/2022 | $11.00 → $8.50 | Outperform | Credit Suisse |
| 3/2/2022 | $11.00 → $8.00 | Outperform | Raymond James |
| 1/26/2022 | $15.00 → $10.00 | Buy | BTIG Research |
| 1/20/2022 | $8.50 → $6.50 | Equal-Weight | Morgan Stanley |
| 11/19/2021 | $15.00 | Buy | Tigress Financial |
| 11/8/2021 | $15.00 → $11.00 | Outperform | Raymond James |
| 8/23/2021 | $11.00 | Equal-Weight | Morgan Stanley |